GeoVax Labs (GOVX) Operating Leases (2025 - 2026)
GeoVax Labs (GOVX) posted quarterly Operating Leases of $323141.0 for Q2 2026, down 44.29% quarter-over-quarter from $580035.0 in Q4 2025.
GeoVax Labs (GOVX) Operating Leases (2025 - 2026) Analysis & Trends
GeoVax Labs (GOVX) has reported Operating Leases for 2 consecutive years, with $323141.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Leases changed N/A year-over-year to $323141.0; the TTM figure through Jun 2026 stood at $323141.0 (changed N/A YoY), while the FY2025 annual figure was $580035.0, changed N/A from the prior year.
- Operating Leases eased to $323141.0 in Q2 2026 per GOVX's latest filing, from $580035.0 in the prior quarter.
- Across five years, Operating Leases topped out at $580035.0 in Q4 2025 and bottomed at $323141.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 323,141.00 |
| Dec 31, 2025 | 580,035.00 |